Presentation - What to control? CQAs and CPPs
3 |What to control?, BWP Workshop on Setting Specifications | Thomas Stangler, September 9th, 2011. QTPP. CQAs. Process Risk Assessment Determine Critical Quality Attributes – linking quality attributes
Download Presentation - What to control? CQAs and CPPs
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
API MPMS Chapter 18.2 Custody Transfer of Crude …
ballots.api.orgINTRODUCTION The API Manual of Petroleum Measurement Standards covers individual standards for sampling, temperature determination, gauging, and quality testing.
PAT and Quality by Design exemplified in a Mock …
gmpeye.co.kr5 Rationale {Current regulatory hurdles in changing without prior approval: zAnalytical or manufacturing processes zEquipment, Sites and Scale zOngoing stability programs {Use process understanding to derive real time release{Need examples as basis for discussion and clarification of uncertainties within industry and authorities {Use as an example …
2015 Standard for Performance Rating Of Positive ...
www.ahrinet.orgAHRI STANDARD 540-2015 1 PERFORMANCE RATING OF POSITIVE DISPLACEMENT REFRIGERANT COMPRESSORS AND COMPRESSOR UNITS Section 1. Purpose 1.1 Purpose. The purpose of this standard is to establish, for Compressors: definitions, test requirements, rating
Instrumentation for the Pharmaceutical Industry
www.metrohmsiam.comAnton Paar has been developing, producing and distributing high-precision measuring and analytical instrumentation for laboratory and process applications since 1922.
Appendix 2 Technical Background Note - Solent …
www.solentcomposites.comAppendix 2 Technical Background Note Title: The assessment of fire, blast barriers, escape routes and temporary refuges (TRs) Introduction This document sets out the technical background for the interventions to